Clinical Trials
Lorus announces down regulation of GTI-2040 molecular target in breast cancer clinical study
Published in Women's Health Weekly, May 15th, 2006
The article, titled "Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment," to be published in the Oncology Reports (2006;15-5:1299-1304), presents a case study from a U.S. National Cancer Institute (NCI)-sponsored phase 2 clinical trial of GTI-2040 in combination with capecitabine in metastatic breast cancer.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Lower breast cancer progression from benign breast disease may be linked to aspirin use - Cancer Mortality
Bilateral salpingo-oophorectomy reduces overall, but not cancer-specific, mortality - Familial Obesity
Weight gain prevention program proves effective in high-risk women with familial obesity - Osteoporosis
Bone fracture incidence is increased in women with pollen-allergy and is related to obesity - Osteoporosis
Osteoporosis risk may be identifiable through dental panoramic radiographs - Allergy & Immunology
Childhood food allergies may be influenced by maternal fish consumption during pregnancy - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
